Olfactory dysfunction may be the only early clinical manifestation in COVID-19 patients with no other significant signs. It is typical of disease and can for testing. The purpose review to provide guidance otorhinolaryngologist problem olfactory SARS-CoV-2 infection. Materials Methods: authors analyzed available data on statistics, symptoms pathogenesis were studied. Toexplain anosmia patients,...

Olfactory dysfunction is closely related to Alzheimer's disease (AD). Yet the mechanism behind this dysfunction remains largely unknown. To clarify the relationship between olfactory and memory deficits, we assessed behavioral and olfactory system pathology in AβPP/PS1 transgenic mice using the olfactory threshold test, the Morris water maze, Western blotting, immunohistochemistry (IHC), and th...

Metabolic syndrome (MetS) is associated with a higher risk of morbidity and/or mortality for various chronic diseases. The aim of this study was to investigate the relationships of MetS and its components with olfactory dysfunction in a representative Korean population. We analyzed the data from the Korean National Health and Nutrition Examination Survey (2008-2010). A total of 11,609 adults wh...

Disorders, Agents, or Events Associated with Decreased Transport of Taste Stimuli to the Taste Buds, 458 Disorders, Agents, or Events Associated with Damage to Taste Sensorineural Structures, 458 Conclusions, 460 References, 460 Olfactory Dysfunction and Its Causes, 450 Disorders Associated with Decreased Transport of Odorant Molecules to the Olfactory Neuroepithelium,453 Disorders, Agents, or ...

Background Evidence for olfactory dysfunction in schizophrenia has been firmly established. However, in the typical understanding of schizophrenia, olfaction is not recognized to contribute to or interact with the illness. Despite the solid presence of olfactory dysfunction in schizophrenia, its relation to the rest of the illness remains largely unclear. Here, we aimed to examine functional co...

Smell loss originates from peripheral disorders, like intranasal obstruction and olfactory cell injury, as well as central pathway diseases. Information derived from electrophysiological and psychophysical tests are useful for identifying loss of smell, but not for discriminating between central and peripheral deficits. This is because conventional imaging modalities are unable to deliver infor...